Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for BYETTA
- Pharmacogenomics of GLP1 Receptor Agonists
- Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.
- Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients
- The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
- Research of Exenatide for Overweight/Obese PCOS Patients With IGR
- Trial of EXenatide in Acute Ischaemic Stroke
- Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases
- The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers
- The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke
- An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
- Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
- Gut Hormones in Obesity, Nicotine and Alcohol Dependence
- Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy
- Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
- Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
- Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes
- GLP-1 Analogs for Neuroprotection After Cardiac Arrest
- Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients
- Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes
- GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration
- Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
- Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying
- Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status
- Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
- Exenatide and Weight Loss for Diabetes Prevention
- Clinical Trial for PB-119 in Healthy Subjects (Phase I)
- Exenatide for Stress Hyperglycemia
- Effect of Exenatide on Liver and Heart Fat and Inflammation
- Exenatide for Myocardial Protection During Reperfusion Study
- An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus
- Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes
- Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage
- Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes
- Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes
- Acute Effect of Exenatide on Brain Glucose Metabolism
- FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
- Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women
- Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
- Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients
- Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
- Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes
- Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist
- Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes
- The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes
- The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
- Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
- New Onset Type 1 Diabetes: Role of Exenatide
- Exenatide in Extreme Pediatric Obesity
- Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)
- The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes
- Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study
- Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)
- A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents
- Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment
- Effects of Exenatide on Hypothalamic Obesity
- Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes
- Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans
- Study Looking at Cardiovascular Effects of Exenatide, Its Blood Pressure Lowering Effect and Its Mechanisms
- Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
- Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation
- Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes
- A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
- The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes
- Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus
- Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
- A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects
- GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children
- Intravenous Exenatide (Byetta) During Surgery
- A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)
- The Effects of Exenatide After Gastric Restriction
- The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects
- Evaluation of Exenatide in Patients With Diabetic Neuropathy
- The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults
- Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function
- Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
- A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)
- Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients
- Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione
- GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
- The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation
- Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects
- How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics
- Role of Exenatide in NASH-a Pilot Study
- CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy
- Bioenergetic Alterations After Exenatide Administration
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin
- Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)
- Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
- Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
- Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only
- A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes
- A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes
- An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes
- Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes
- A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients
- A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus
- The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women
- Role of Exenatide in Type 1 Diabetes
- Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes
- Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes
- A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes
- Safety and Efficacy of Exenatide as Monotherapy
- Effect on Weight Loss of Exenatide Versus Placebo
- A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients
- Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes
- Exenatide Versus Glimepiride in Patients With Type 2 Diabetes
- The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes
- Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin
- Exenatide and Metformin Therapy in Overweight Women With PCOS
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin
- Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.
- Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)
- The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus
- Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes
- An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
- Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes
- Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy
- Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
- Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes
- Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
- Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
Clinical trials list
click for details